826253--3/25/2008--AURA_SYSTEMS_INC

related topics
{stock, price, share}
{product, liability, claim}
{control, financial, internal}
{customer, product, revenue}
{acquisition, growth, future}
{stock, price, operating}
{property, intellectual, protect}
{competitive, industry, competition}
{condition, economic, financial}
{cost, operation, labor}
Risk Factors Relating to Our Business We have a history of losses and we may not be profitable in any future period. we are unable to raise capital, our ability to implement our current business plan and ultimately our viability as a company could be adversely affected. Our revenues have declined significantly in recent years. Our success over the short-term depends on the commercial success of the AuraGen products, as we are not currently engaged in any other line of business. We may have difficulty managing our growth. The market acceptance of the AuraGen Our business may be adversely affected by industry competition. We depend on our intellectual property to provide us with a competitive advantage. We depend on third party manufacturers for certain product components. We will need to renew sources of supply to meet increases in demand for the AuraGen Risks Relating to Our Common Stock Because our operating results have been uneven and may continue to fluctuate, this could affect our stock price. We have a history of filing late periodic reports with the SEC. We may issue additional shares of our authorized common stock without obtaining the approval of our stockholders. Because our common stock is not traded on a national or regional market, liquidity for our common stock could be adversely impacted. Because our common stock is subject to rules governing low priced securities, market liquidity for our common stock could be adversely impacted. The potential exercise of outstanding warrants and options could adversely affect the market price of our common stock, dilute the holdings of existing stockholders and impede our ability to obtain additional equity financing. We do not expect to pay dividends on our common stock in the foreseeable future.

Full 10-K form ▸

related documents
826253--3/25/2008--AURA_SYSTEMS_INC
724910--5/25/2007--NVE_CORP_/NEW/
826253--6/13/2008--AURA_SYSTEMS_INC
1032863--4/13/2006--FORCE_PROTECTION_INC
826253--6/15/2009--AURA_SYSTEMS_INC
1036968--3/29/2010--VAXGEN_INC
1036478--4/10/2008--WWA_GROUP_INC
1413754--7/14/2009--Swav_Enterprises_Ltd.
1378706--3/18/2008--AMERICAN_DG_ENERGY_INC
1450552--12/29/2010--Dafoe_Corp.
1104672--4/11/2008--MONTANA_MINING_CORP
941685--4/15/2008--IMAGEWARE_SYSTEMS_INC
1438672--9/7/2010--Orofino_Gold_Corp
1160164--12/15/2010--Biomass_Secure_Power_Inc
813747--1/4/2006--SPESCOM_SOFTWARE_INC
919567--9/22/2006--RENAISSANCE_CAPITAL_GROWTH_&_INCOME_FUND_III_INC
1378706--3/20/2009--AMERICAN_DG_ENERGY_INC
1094816--7/6/2010--VOICE_MOBILITY_INTERNATIONAL_INC
1121827--3/6/2009--BIG_SKY_INDUSTRIES_VI_INC
1078383--3/13/2008--IPARTY_CORP
1042610--10/13/2010--TRB_SYSTEMS_INTERNATIONAL_INC
1014343--3/31/2008--Organic_To_Go_Food_CORP
3116--3/30/2006--AKORN_INC
852437--9/28/2007--AVATECH_SOLUTIONS_INC
802257--9/28/2009--BRAIN_TREE_INTERNATIONAL_INC
1115975--4/15/2010--SILVERGRAPH_INTERNATIONAL_INC
1144225--4/12/2010--instaCare_Corp.
1144225--5/18/2009--instaCare_Corp.
1405350--4/10/2009--RxBids
1030839--2/5/2009--Synovics_Pharmaceuticals